{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=San+Diego&page=31&state=California", "query": { "state": "California", "city": "San Diego", "page": 31 }, "page_size": 10 }, "pagination": { "page": 31, "page_size": 10, "total_count": 4980, "total_pages": 498, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=San+Diego&page=32&state=California&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=San+Diego&page=30&state=California&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T00:52:36.032Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01432665", "title": "Lybrido for Female Sexual Dysfunction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypoactive Sexual Desire Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Sildenafil", "type": "DRUG" }, { "name": "Testosterone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emotional Brain NY Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "21 Years to 70 Years · Female only" }, "enrollment_count": 196, "start_date": "2011-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-07-29", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 14, "location_summary": "San Diego, California • Washington D.C., District of Columbia • Brooksville, Florida + 11 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Brooksville", "state": "Florida" }, { "city": "North Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01432665" }, { "nct_id": "NCT03170583", "title": "SJM Brady MRI Post Approval Study", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bradycardia" ], "interventions": [ { "name": "St. Jude Medical Tendril MRI™ lead", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1768, "start_date": "2017-06-08", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2020-07-28", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 66, "location_summary": "Phoenix, Arizona • Jonesboro, Arkansas • Little Rock, Arkansas + 62 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03170583" }, { "nct_id": "NCT00004353", "title": "Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mitochondrial Myopathy", "MELAS Syndrome", "Lactic Acidosis" ], "interventions": [], "intervention_types": [], "sponsor": "National Center for Research Resources (NCRR)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 35, "start_date": "1978-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2008-07-10", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004353" }, { "nct_id": "NCT06909565", "title": "Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Percutaneous Coronary Intervention", "Peripheral Endovascular Intervention" ], "interventions": [ { "name": "Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL", "type": "DRUG" }, { "name": "Normal Saline (Placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6000, "start_date": "2025-07-23", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-10-29", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 149, "location_summary": "Alexander City, Alabama • Birmingham, Alabama • Huntsville, Alabama + 131 more", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Avondale", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06909565" }, { "nct_id": "NCT00671502", "title": "A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lower Back Pain" ], "interventions": [ { "name": "Carisoprodol SR", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Meda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 840, "start_date": "2008-04", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2011-11-09", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 68, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Montgomery, Alabama + 58 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00671502" }, { "nct_id": "NCT00114101", "title": "Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "DS Stage I Multiple Myeloma", "DS Stage II Multiple Myeloma", "DS Stage III Multiple Myeloma", "Refractory Multiple Myeloma", "Smoldering Multiple Myeloma" ], "interventions": [ { "name": "Autologous Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Peripheral Blood Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Placebo Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 460, "start_date": "2004-12-15", "completion_date": "2027-03-06", "has_results": true, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 140, "location_summary": "Scottsdale, Arizona • Duarte, California • Sacramento, California + 103 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00114101" }, { "nct_id": "NCT02298829", "title": "Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Peyronie's Disease" ], "interventions": [ { "name": "Subjects Previously Treated with AA4500", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endo USA Inc., a Keenova Therapeutics Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "MALE", "summary": "18 Years to 90 Years · Male only" }, "enrollment_count": 184, "start_date": "2014-11", "completion_date": "2018-04-09", "has_results": false, "last_update_posted_date": "2018-06-20", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 30, "location_summary": "Anchorage, Alaska • Burbank, California • Laguna Hills, California + 27 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Burbank", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02298829" }, { "nct_id": "NCT07200830", "title": "Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Castration-Resistant Prostate Carcinoma", "Metastatic Prostate Adenocarcinoma", "Stage IVB Prostate Cancer AJCC v8" ], "interventions": [ { "name": "Lutetium Lu 177 Vipivotide Tetraxetan", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Patient Monitoring", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "PSMA PET Scan", "type": "PROCEDURE" }, { "name": "MRI", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 1524, "start_date": "2026-03-31", "completion_date": "2034-09-09", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 142, "location_summary": "Anchorage, Alaska • Bakersfield, California • Irvine, California + 117 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Bakersfield", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07200830" }, { "nct_id": "NCT02556177", "title": "Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Concussion", "Traumatic Brain Injury" ], "interventions": [ { "name": "MRI", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "GE Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "15 Years to 50 Years" }, "enrollment_count": 477, "start_date": "2015-11", "completion_date": "2018-01-31", "has_results": true, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 7, "location_summary": "San Diego, California • San Francisco, California • Miami, Florida + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "New York", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02556177" }, { "nct_id": "NCT01479465", "title": "Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "Simtuzumab", "type": "BIOLOGICAL" }, { "name": "Placebo to match SIM", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "Fluorouracil", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 266, "start_date": "2011-12", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2019-04-17", "last_synced_at": "2026-11-04T00:52:36.032Z", "location_count": 56, "location_summary": "Huntsville, Alabama • Gilbert, Arizona • Alhambra, California + 49 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Alhambra", "state": "California" }, { "city": "Bakersfield", "state": "California" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01479465" } ] }